-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"We believe that patients similar to this trial should now use pluggable heart monitors for long-term monitoring
Lee H.
Lee H.
Vascular Neurologist, Massachusetts General Hospital | Neurologist
Executive Vice Chairman of the Department of Neurology
Executive Vice Chairman of the Department of NeurologyDirector, Telemedicine Center, Massachusetts General Hospital
Director, Telemedicine Center, Massachusetts General HospitalFor patients who have experienced certain common types of strokes, implanting a small chip under the skin can help doctors predict the likelihood of them having a stroke again, thereby predicting the likelihood that they will benefit from preventive treatment
Approximately 800,000 people in the United States have a stroke each year, and as many as a quarter of stroke patients have had a stroke before
Recent studies have shown that a small chip implanted under the skin can monitor heart rate and rhythm, and help doctors detect atrial fibrillation in patients who have experienced cryptogenic stroke
In the Stroke of Known Cause and Underlying Atrial Fibrillation (Stroke AF, Stroke of Known Cause and Underlying Atrial Fibrillation) trial, 492 patients were randomized and received insertable heart monitors or routine care within 10 days after the first stroke ( Including external cardiac monitoring through ECG or other tracking methods), after which a 12-month follow-up will be completed
The chip detected atrial fibrillation in 12.
Richard a.
Senior author Dr.
Dr.
The next steps of the study include factors that predict the duration and extent of atrial fibrillation and arrhythmia
About Massachusetts General Hospital
Founded in 1811, Massachusetts General Hospital is the largest teaching hospital originally established by Harvard Medical School
reference:
reference:Original link: https://
Original link: https:// Journal of the American Medical Association: https://jamanetwork.com/journals/jama/article-abstract/2780490
com/journals/jama/article-abstract/2780490